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Abstract 
Background: To analyze the efficacy of Nigella 
sativa (Kalongi) for the treatment of hyperlipidemia 
in Sprague Dawley rats. 
Methods: Twenty  albino rats were divided in two 
groups. Both groups were fed on ad libitum diets for 
02 weeks. Then cholesterol rich diet was given to all 
rats for 08 weeks followed by treatment with Kalonji 
for 06 weeks in group II but no treatment in Group I. 
Blood samples were collected and serum of all rats 
were analyzed in three phases i.e., at baseline, after 
cholesterol rich diet and after treatment period for 
serum cholesterol, serum triglycerides levels, HDLC, 
LDLC along with serum transaminase levels (ALT). 
 Results: Baseline levels of all parameters were 
comparable  in both groups. The cholesterol rich diet 
affected all parameters of lipid profile. Nigella sativa 
(kalonji) showed significant improvement in the 
lipid profile of rats. The p value < 0.05 of group I and 
II documented that Nigella sativa (kalonji) had 
significantly affected the lipid profile as compared to 
control group. No significant difference was noted in 
ALT levels between two groups at the end of 
treatment (p > 0.05).  
Conclusion: Nigella sativa reduces cholesterol and 
triglycerides, with adequate safety profile  
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Introduction 
          Hypercholesterolemia is one of the major risks 
for heart diseases. The evidence confirms that elevated 
levels of low-density lipoprotein cholesterol (LDLC) 
are associated with increased risk of atherosclerosis 
and lowering LDL-C reduces cardiovascular risk. 
Hyperlipidemia is a well known unique and sufficient 
cause for the development of coronary heart disease  
without the episode of hypertension, diabetes, 
smoking, male gender and inflammation. 1,2  
     Hyperlipidemia can be controlled through dietary 
modification or by drug therapies. Statins (HMG-CoA 
reductase inhibitors) are most commonly used. Studies 
are associated with side effects including 
gastrointestinal disorders, myalgia, arthralgia, upper 
respiratory infections, headache, abdominal pain, 
constipation and nausea. Biochemical abnormalities 
have occurred with simvastatin treatment with 
elevation of serum transaminase levels.3 
     Nigella sativa (Kalonji) is a flowering plant, belongs 
to the family Ranunculaceae and genus Nigella. It is a 
widely investigated herb for use as medicine. It has 
been traditionally used as medicine in Mediterranean 
region, Asia and Africa. The usefulness of Nigella 
sativa (Kalonji) has been mentioned in various 
Ahadees-e-Nabvi. The prophet (PBUH) said, "Hold 
onto the use of the black seed for it has a remedy for 
every illness except death". Different scholars reported 
Nigella sativa as a beneficial medicinal herb like Al- 
Biruni, Ibne-Sina and Greek physician Dioscoredes. 
Nigella sativa is a very effective herb and was 
traditionally used for many different ailments like 
bronchial asthma inflammatory diseases, for the 
enhancement of milk production, bronchititis and  
rheumatism. Its various forms like the oil form and 
powder form are used in the treatment of different 
diseases. The ingredients of seeds of Nigella sativa 
were found effective for reducing hepatotoxicity  and 
nephrotoxicity.Multi-systemic beneficial actions of 
Nigella sativa are also reported including 
hypocholesterolemic effects  & anti-oxidant effects.4-11  
 
Materials and Methods 
     In this case control study, of 16 weeks duration,  
twenty healthy rats, 90 – 120 days of age were 
included. The rats were obtained from National 
institute of Health, NIH, Islamabad. They were kept 
under standard conditions with a daily photoperiod of 
12 hours light and 12 hours dark at temperature ± 5°C 
at animal house of NIH, Islamabad.The sample size 
was divided in two equal groups, 10 in each group. 
Group I( Control Group) did not receive any treatment 
during third phase of study. Group II( Experimental 
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Group) received Nigella sativa (1000 mg/Kg) during 
third phase of study. 
     The study was carried out in three phases. 1st and 
2nd phase of the study were same for both groups. 
However, during third phase, the groups differed on 
treatment basis. During first phase, the rats of all 
groups were kept under optimum temperature 
(24±2OC) and hygienic conditions with food and water 
available at all times for acclimatization with the 
environment. In 2nd phase, the rats were given 
cholesterol rich diet (cholesterol powder) for 08 weeks. 
The diet was given ad libitum to the rats. The average 
per day feed of a rat is about 20 gm/day. The 
constituents of the routine diet includes, wheat flour 
(28.5%), wheat bran (28.5%), fish meal (15%), dried 
skimmed milk (20%), soya bean vegetable Oil (5%). 
molasses (2%), common salt (0.5%), vitaminera premix 
(0.5%). During 2nd phase, supplementation of 
cholesterol rich powder as 200gm/5 Kg was done in 
the routine diet for all rats. The average consumption 
of feed by a rat is about 20gm/day. In this way, 5 kg 
feed serves for one week for rats in study population 
(20 rats). The third phase comprised of treatment. 
During this phase, one group did not receive any 
treatment, second group received Nigella sativa. The 
duration of this phase was six weeks. At the end of 
each phase blood samples of all rats were taken for 
lipid profile and ALT estimations. 
     Fasting (12–14 hour fasting) blood sample of all the 
rats (both groups) were taken via tail vein. The blood 
samples were collected in plain tubes. Baseline blood 
samples were collected  before the start of cholesterol 
rich diet. Samples were collected before the initiation 
of cholesterol rich diet (baseline), after completion of 
08 weeks of cholesterol rich diet  and after completion 
of six weeks of Nigella sativa  administration.   
     Serum cholesterol, serum triglycerides, serum HDL 
and serum ALT levels were estimated in all the blood 
samples. Serum LDL was also estimated by using the 
formula:LDL=Total Cholesterol-HDL Cholesterol-
TG/5 
 
Results 
    Mean baseline weight of rats was 215.16±14.17gms 
and 241.67±14.10gms at the end of 2nd phase. There 
was no significant difference in weight of rats between 
two groups (with p value 0.973 and 0.826 respectively 
p>0.05) at this level. The mean weight during third 
phase of study was 221.5±14.51gm. During 3rd phase, 
there was difference in weight of rats between control 
vs Kalonji group (Table 1). Significant difference was 
observed in weight of rats between 1st vs 2nd phase of 
study with p value .000 (p<0.05). Insignificant 
difference in the weight of control group rats was 
observed in 2nd vs 3rd phase of study. Statistically 
significant difference was noted in weight of rats of 
Kalonji group in 2nd vs 3rd phase of study 
     Average baseline cholesterol level was 99.43±3.72 
mg/dl (range 90 to 108 mg/dl) and 195.75±5.34 
mg/dl. There was insignificant difference in the 
baseline values of cholesterol level between two 
groups in both phases. Significant difference was 
observed in the 3nd phase cholesterol levels between 
two groups. Insignificant difference was observed in 
control group between 2nd vs 3nd phase of study but 
experimental group showed significant difference in 
cholesterol levels between 2nd vs 3rd phase (after 
treatment).      Average HDL level in study population 
at the end of 1st phase was 39.8±1.42 mg/dl. 
Insignificant difference in HDL levels of two groups 
was observed at this level. The average HDL level of 
rats in control group of study was 39.7±1.42 mg/dl, 
20.9±1.45 mg/dl and 31.2±2.62 mg/dl during 1st, 2nd 
and 3rd phase respectively. Significant difference was 
noted in HDL level of rats between 1st vs 2nd phase of 
study in control group and insignificant difference in 
the cholesterol level of control group rats was 
observed in 2nd vs 3rd phase of study. Insignificant 
difference was noted between 1st and 3rd phase HDL 
levels in rats of Kalonji group. 
Table 1: Average values of different parameters 
in study population 
Parameters Phases Study Population 
Weight 1st Phase 215±12.12 
 2nd Phase   242±13.02 
 3rd Phase 224.5±11.57 
Cholesterol 1st Phase 99.15±3.81 
 2nd Phase 195.75±5.34 
 3rd Phase 130±30.34 
Triglycerides 1st Phase 77.4±4.15 
 2nd Phase 102.7±3.58 
 3rd Phase 84.3±8.58 
HDL-C 1st Phase 39.75±1.45 
 2nd Phase 21±1.55 
 3rd Phase 35.3±4.74 
LDL-C 1st Phase 43.72±3.75 
 2nd Phase 153.21±5.4 
 3rd Phase 77.84±33.1 
ALT 1st Phase 30.25±7.13 
 2nd Phase 29.8±7.19 
 3rd Phase 30.15±5.90 
Journal of Rawalpindi Medical College (JRMC); 2013;17(1):144-147 
 146 
    Average value of triglycerides at the end of 1st phase 
was 77.5±4.11 mg/dl . There was insignificant 
difference in baseline and 2nd phase triglyceride levels 
between two groups. Significant difference was noted 
in triglyceride levels between control group vs Kalonji 
group at the end of 3rd phase. Significant difference 
was noted in triglyceride level of rats between 1st vs 
2nd phase, whereas insignificant difference in the 
triglycerides level was observed in 2nd vs 3rd phase of 
study in control group rats. Insignificant difference 
was noted between 1st and 3rd phase triglyceride levels 
of rats in Kalonji group. 
     Mean LDL level after completion of 1st phase was 
44±3.68 mg/dl .Insignificant difference was observed 
in baseline and 2nd phase LDL levels of both groups. In 
3rd phase, there was significant difference in LDL 
levels between control vs kalonji group.  
Significant difference was noted in LDL level of rats 
between 1st vs 2nd phase, whereas insignificant 
difference was observed in 2nd vs 3rd phase of study in 
control group rats. In Kalonji group, significant 
difference was observed in LDL levels in this group 
between 1st vs 2nd and 2nd vs 3rd phase of study. 
However, insignificant difference was noted between 
1st and 3rd phase LDL levels in Kalonji group. 
    At completion of 1st phase, the mean ALT level of 
study population was 30.17±7.30 U/l . Statistically 
insignificant difference was observed in baseline, 2nd 
phase and 3rd ALT levels of control and kalonji groups.  
 
Discussion 
     The basic mechanism for the development of 
coronary artery disease involves mainly retention and 
deposition of serum lipids especially LDL-C in the 
coronary arteries .This will cause the flow of blood to 
decrease towards the heart muscle.12 The available 
treatment involves drugs causing the lowering of 
cholesterol levels. However, some side effects of few of 
these drugs are reported which limit their usage in 
certain individuals. 13  
     Medicinal plants are getting the attention of 
medical researcher to treat different disease other than 
synthetic medicine. Different herbal treatments were 
tried for the treatment of hypercholesterolemia. The 
Nigella sativa commonly known as Kalonji is one such 
herb. In present study, its efficacy was tried for the 
treatment of hyperlipidemia in rats. 14  
     The comparison of baseline parameters at the end 
of first phase of study, including weight of the rats, 
serum cholesterol, serum triglycerides, serum HDL-C 
and serum LDL-C levels in both groups showed 
statistically insignificant difference (p>0.01). Hence the 
effects observed later during the study in each group 
are related to the diet, treatment etc during the study 
and there was no study bias in any group. Study 
carried out on Sprague-Dawley rats  observed almost 
same baseline values of different parameters of lipid 
profile. 15  
     There was 26.5 gm increase in average weight of 
rats after cholesterol rich diet of eight weeks. An 
average increase of 38 grams in weight of the rats was 
observed by Matos et al. 16 The increase in weight is 
relatively higher as compared to present study. The 
weight increase is likely due to the fact that the 
authors included soyabean oil and fiber content in diet 
which is produced relatively higher weight. In 2011, 
A.Rezq and Al-Khaimesy studied the effects of 
cholesterol diet in Sprague-Dawley rats in which 
sheep fat and 0.5% cholic acid was also used in 
addition to 1% cholesterol to induce hyperlipidemia. 
The authors observed 33.14 gm gain in weight in 
positive group of study as compared to negative 
control group after cholesterol rich diet.17   
     The average cholesterol level showed 51% increase 
and there was an increase of 71.4% in LDL-C as 
compared to baseline levels. Matos et al, reported the 
average increase in cholesterol level and LDL-C as 56% 
and 78.5% respectively after cholesterol rich diet 
supplementation of eight weeks. The increase in 
cholesterol levels, LDL-C levels is relatively higher as 
compared to our study.  The inclusion of soyabean oil 
in addition to cholesterol by Matos et al., in diet, has 
produced relatively higher values of total cholesterol 
and LDL-C levels.16 In study of Rezq and Al-
Khaimesy, comparing the control negative group with 
positive group, who received fatty diet, the authors 
observed 44% increase in serum cholesterol levels, 33% 
and 83% increase in serum triglycerides and LDL-C 
levels respectively. 17 
    There is a decrease of 47% in HDL-C levels at the 
end of 2nd phase of our study and 34% in study of 
Matos et al. (2005). A.Rezq and Al-Khaimesy (2011) 
observed 33% decrease in HDL-C levels in positive 
group who received sheep fat and 1% cholesterol for 
six weeks as compared to negative control who 
received standard diet. The slight variations of HDL-C 
levels between our study, Matos et al.and Rezq and 
Al-Khaimesy is due to minor differences in study 
design. Moreover, the diet supplementation was 
continued for six weeks as compared to eight weeks in 
our study.   
     During the third phase of the present study, control 
group received no treatment whereas, experimental 
group received kalonji (1000 mg/kg/day) for 06 
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weeks. The treatment showed a significant change in 
the lipid profile of the rats. It showed 48.4% 
improvement (reduction) in total cholesterol levels. 
There was 70% and 25.3% reduction in LDL-C and 
triglycerides levels respectively at the end of 3rd phase. 
Moreover, HDL-C levels of rats in this group showed 
53.5% improvement after kalonji treatment. The same 
dose of Nigella sativa was used by other authors1 and 
comparable results were found in their study in terms 
of reduction in total cholesterol levels, LDL-C levels 
and serum triglycerides levels of the rats with an 
increase in HDL-C levels.18 In another study of rats  
kalonji was added to the diet of the rats in a dose of 
30mg/kg body weight, simultaneously with 
cholesterol rich constituents of the diet. 19 It was 
concluded that the group with kalonji showed 
comparatively lesser rise in total serum cholesterol 
level of the rats after 20 weeks of the treatment. Similar 
effects of Nigella sativa on lipid profile of albino rats 
was observed by other authors.20,21  In another study  
kalonji was used as an effective herbal drug in 
maintaining lipid profile in normal states and also no 
adverse effects were observed in this study.22 The 
change noted after four weeks of two spoons of kalonji 
powder per day in mentioned study was 8.83%, 
17.41% and 11.94% in total cholesterol, LDL-C and 
HDL-C respectively as compared to baseline levels. 
Although, the percent change noted after treatment 
was statistically significant (p <0.001), yet it differs 
with our study in terms of percentage. The probable 
reasons of difference could be the duration of 
treatment (04 weeks versus 06 weeks in our study).  
 
References 
1. Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery 
disease in the developing world. American  Heart Journal, 
2004; 148: 7-15. 
2. Raal F, Schamroth C, Blom D, Marx J.A South African survey 
on the under treatment of hypercholesterolaemia. 
Cardiovascular Journal of Africa 2011; 22: 234-40. 
3. Grundy SM, Cleeman JI, Merz CN. Coordinating Committee 
of the National Cholesterol Education Program. Implications 
of recent clinical trials for the National Cholesterol 
Education Program. Circulation 2004; 110: 227-39. 
4. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan 
ST. Potential of spice-derived phytochemicals for cancer 
prevention. Planta Med 2008; 74: 1560-69. 
5. Ghaznavi K.  Tibb-e-Nabvi aur Science. 8th Ed. Lahore, 
1992; Alfaisal:  246-54. 
6. Said HM. Pharamacographia Indica. Hamdard, 1972; 15: 
28-30 
7. Nagi M N, Alam K, Badary O A, al-Shabanah O. A. 
Thymoquinone protects against carbon tetrachloride 
hepatotoxicity in mice via an antioxidant mechanism. 
Biochem Mol Biol Int 1999;47:153–59 
8. Al-Shabanah OA, Badary OA, Nagi MN, al-Gharably, N.M. 
Thymoquinone protects against doxorubicin-induced 
cardiotoxicity . J Exp Clin Cancer Res 1998; 17: 193–98. 
9. Ali BH and Blunden G. Pharmacological and toxicological 
properties of Nigella sativa. Phytother. Res 2003; 17: 299-
305. 
10. Ali BA, Bamosa AO, Al-Hawasawi ZA. Effect of Nigella sativa 
on blood lipids in normal rats. Arab Gulf J Sci Res  2003; 21: 
102-109. 
11. Kanter M, Meral I , Dede S.Effects of Nigella sativa L and 
Urtica dioica L on lipid peroxidation, antioxidant enzyme 
systems and liver enzymes in CCL4 treated rats. J Vet Med A 
Physiol Pathol Clin Med 2003; 50: 264-68. 
12. Rudling M. Lowering of LDL cholesterol prevents 
cardiovascular diseases. Lakartidningen 2006; 103(43): 
3278-82. 
13. Thompson PD, Clarkson P,  Karas R H. Stain-associated 
myopathy. JAMA, 2003;289(13): 1681-90. 
14. Ghurbakhshani A, Asghar J, Bashir  Z, Chaudhry  A M. 
Herbal Medicine is effective for lowering serum lipids with 
least side effects. IJPRD 2012; 4(1): 140-44 
15. Rahim, A and  Naveed, A.K. Effect of smoke on PAPP-A and 
lipid profile in normal rats. J Pak Med Assoc 2011; 61(5): 
496-97. 
16. Matos, S. L., Paula, H., Pedrosa, M. L., Rinaldo dos Santos, R. 
C., de Oliveira, E. L. Dietary models for inducing 
hypercholesterolemia in rats. Braz. Arch. Biol. Technol 
2005; 48(2): 203-09.  
17.  Rezq A. and E El-Khamisy, A.  Hypolipideimic and 
hypocholesteremic effect of pine nuts in rats fed high fat, 
Cholesterol-Diet. World Applied Sciences Journal 2011;  
15(12): 1667-77 
18. Al-Naqeep, G., Al-Zubairi, A. S.,  Ismail, M.,  Hj Amom, Z. 
Antiatherogenic Potential of Nigella sativa Seeds and Oil in 
Diet-Induced Hypercholesterolemia in rabbits. Evidence-
Based Complementary and Alternative Medicine 2011;. 8 
pages doi:10.1093/ecam/neq071 
19. Dahri, A. H., Chandio, A. M., Rahoo, A. A, Memon, R. A. 
Effect of Nigella sativa (kalonji) on serum cholesterol of 
albino rats. J Ayub Med Coll Abbotabad 2005; 17:72-4 
20. Buriro, M. A., Allah Ditta,  Tayyab, M. Nigella sativa 
(Kalonji); Effects on serum cholesterol of Albino rats. 
Professional Med J 2011 . 18(1), 142-46 
21. el-Dakhakhny, M., Mady, N. I. and Halim, M. A.  Nigella 
sativa L. oil protects against induced hepatotoxicity and 
improves serum lipid profile in rats. Arzneimittelforschung 
2000; 50(9): 832-36.  
22. Ghurbakhshani A, Asghar J, Bashir Z, Chaudhry A M, Asif S. 
Herbal Medicine is effective for lowering serum lipids with 
least side effects. IJPRD 2012 . 4(1), 140-44 
 
                                                          
 
